| Document Date: 2014-10-21 10:06:16
Open Document File Size: 747,19 KBShare Result on Facebook
City Reference / / Company Auxilium Pharmaceuticals Inc. / / IndustryTerm treatment of male urological diseases / unused reconstituted solution / injection site / TREATMENT OF PEYRONIE’S DISEASE / rubber stopper / healthcare / therapeutic applications / / MedicalCondition Dupuytren’s Contracture / male urological diseases / disease / OR OTHER SERIOUS PENILE INJURY IN THE TREATMENT OF PEYRONIE’S DISEASE / Carcinogenesis / anaphylaxis / pain / serious penile injury / PIP joint contracture / serious injury / contracture / Dupuytren’s Contracture XIAFLEX / minimal depression / Allergic Reactions / curvature deformity / PIP contracture / hypersensitivity / Peyronie’s disease / permanent injury / contractures / Other Serious Injury / paresthesia / / Organization Administration for Peyronie / DOSAGE AND ADMINISTRATION / FDA / Administration for Dupuytren / / Person Tendon Rupture / / / Position investigator / DISEASE Corporal / affecting MP / MP / Corporal / / Product alprostadil / XIAFLEX injections / sodium chloride / calcium chloride / The second XIAFLEX injection / XIAFLEX injection / / Technology Pharmacokinetics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XIAFLEX safely and effectively. See full prescribing information for XIAFLEX. XIAFLEX® (collagenase clostridium his